Argentina inches closer to first locally made cannabis medicine

Argentina might have the first locally-manufactured medical cannabis product as soon as early 2021.

Italy backtracks on medical CBD decree

The Italian Ministry of Health declined to take action under a decree that would have added certain CBD preparations into the table of medicines in its narcotics law, according to a recent notice in the country’s Official Gazette.

WHO cannabis recommendations still face uphill battle for adoption

The World Health Organization’s cannabis scheduling recommendations appeared to have limited support at a United Nations Commission on Narcotic Drugs (CND) “intersessional” meeting on Thursday in Vienna.

Spain still won’t allow local cannabis market, even as exports are occurring

Spain has several medical cannabis licensed producers, and at least one already exports flower to countries such as Germany.

Insurance-covered medical cannabis falls for the first time in Germany

Insurance reimbursements for cannabis in Germany dropped for the first time – on a quarterly basis – since the current medical program started in early 2017, according to new data for the quarter ended June 30, 2020.

German group rejects CBD narcotic classification, wants sales only via prescription

An association of pharmacies dispensing medical cannabis in Germany spurned the idea that CBD ought to be considered a narcotic but wants the cannabinoid to remain available only via prescription.

Some WHO cannabis recommendations draw strong opposition at recent UN meeting

Two of the World Health Organization’s (WHO) cannabis scheduling recommendations might face an uphill battle getting adopted later this year by the United Nations’ Commission on Narcotic Drugs (CND).

UK down-schedules Epidyolex to lowest level for controlled drugs

The United Kingdom has down-scheduled Epidyolex to the lowest level of control for drugs, greatly easing restrictions on the cannabidiol medicine and reducing administrative processes for companies wanting to supply it.